Desfuroylceftiofur (DFC) is a bioactive ␤-lactam antibiotic metabolite that has a free thiol group. Previous experiments have shown release of DFC from plasma extracts after addition of a disulfide reducing agent, suggesting that DFC may be bound to plasma and tissue proteins through disulfide bonds. We have reacted DFC with [Arg 8 ]-vasopressin (which has one disulfide bond) and bovine insulin (which has three disulfide bonds) and analyzed the reaction products by use of electron capture dissociation Fourier transform ion cyclotron resonance mass spectrometry (ECD FT-ICR MS), which has previously shown preferential cleavage of disulfide bonds. We observe cleavage of DFC from vasopressin and insulin during ECD, suggesting that DFC is indeed bound to peptides and proteins through disulfide bonds. Specifically, we observed dissociative loss of one, as well as two, DFC species during ECD of
C eftiofur is a widely used broad-spectrum thirdgeneration cephalosporin antibiotic approved for use to treat infections in cattle, swine, sheep, goats, turkeys, and chickens. The four-membered ring structure of ␤-lactam antibiotics (which include penicillins and cephalosporins) is responsible for their antimicrobial activity against gram-positive and gram-negative bacteria by covalently binding to, and interrupting the function of, enzymes responsible for bacterial cell wall synthesis. Upon intramuscular injection, ceftiofur is rapidly metabolized (t 1/2 Ͻ 10 min) to desfuroylceftiofur (DFC) through hydrolytic cleavage of its thioester bond, generating furoic acid and a sulfhydryl moiety on DFC ( Figure 1) . Previous experiments have shown release of DFC from plasma extracts after addition of a disulfide reducing agent, suggesting that DFC is bound to plasma and tissue proteins at cysteine residues via disulfide bonds [1, 2] . It is estimated that 89% of DFC is covalently bound, through disulfide bonds, to plasma and tissue proteins. The remaining 11% is "free" in the form of the metabolite: Desfuroylceftiofur cysteine disulfide. DFC bound to amino acids, peptides, or proteins through disulfide bonds retains its antibacterial activity because its ␤-lactam ring remains intact.
With the advent of electrospray ionization (ESI) [3] and matrix-assisted laser desorption/ionization (MALDI) [4, 5] mass spectrometry, it has become relatively easy to desorb and ionize high molecular weight biomolecules into the gas phase. The higher charge states achievable with ESI lower the m/z of high molecular weight proteins to within the upper mass range (m/z 2000 -3000) of quadrupole, ion trap, and Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometers. The number of positive charges (protons) that can attach to a protein depends on the number, location, and basicity of the protonation sites in the protein, the pH of the solution, and ESI source conditions. The side chains of basic residues (arginine, lysine and histidine) are the most favored protonation sites [6] .
A number of techniques have been developed to dissociate multiply protonated peptides and proteins to identify primary sequence and post-translational modifications. These techniques include: Collision-activated dissociation (CAD) [7] , infrared multiphoton dissociation (IRMPD) [8] , surface induced dissociation (SID) [9] , blackbody infrared radiative dissociation (BIRD) [10] , sustained off-resonance irradiation/collision activated dissociation (SORI-CAD) [11] , and electron capture dissociation (ECD) [12] [13] [14] . With the exception of ECD, all of the foregoing techniques involve "ergodic" dissociation mechanisms. Ergodic dissociation involves increasing the internal energy of an ion via absorption of infrared radiation or collisions with background neutrals or collision with a surface. The energy deposited into an ion is randomized among all the vibrational degrees-of-freedom. After energy redistribution, dissociation occurs statistically, i.e., random localization of energy into a vibrational mode sufficient to result in bond rupture. The timescale for ergodic dissociation (10 Ϫ9 -10 Ϫ3 s) depends on the ion's internal energy, the number of vibrational modes, and the activation barriers for bond rupture. In contrast, ECD is considered to involve a non-ergodic/non-statistical dissociation mechanism, i.e., fragmentation occurs on a time scale that is much shorter (ϳ10 Ϫ12 s) than the time necessary for energy randomization. ECD utilizes capture of low energy electrons by multiply protonated peptides (or proteins). Electrons generated from a heated filament or dispenser cathode (either internal or external to the bore of the magnet) react with multiply protonated peptide or protein ions in the cell of an FT-ICR mass spectrometer [12] [13] [14] [15] [16] [17] . The energy from recombination is at least 4 -6 eV. The mechanism of ECD is still a matter of ongoing investigation and debate [13, 14, 18, 19] . However, regardless of the mechanism (or mechanisms) involved, ECD produces odd-electron ions ("distonic radical cations") from the even-electron ions generated by the initial ionization process.
ECD has shown unusually strong preference for the dissociation of disulfide bonds in addition to extensive cleavage of backbone amide bonds in peptides and proteins. Consequently, it has rapidly been exploited in "top-down" proteomics research because of the high sequence coverage obtained [20, 21] . In addition, because of the non-ergodic nature of ECD, non-covalent interactions are not affected, and thus tertiary and quarternary structures are left intact [22] [23] [24] . ECD has also been shown to be useful in identifying the location of co-and post-translational modification. Ergodic dissociation techniques may cause dissociative loss of protein modifications, making it difficult to determine the site of attachment. ECD has the advantage of cleavage of the peptide backbone with retention of the modification, allowing the site of the modification to be identified [25] [26] [27] [28] [29] [30] .
It is well known that drugs in general, and antibiotics in particular, often have complex and sometimes unexpected interactions with biomolecules beyond their intended target. To analyze drug/target and drug/nontarget interactions, it is important to examine the nature of the drug/biomolecule binding, i.e., covalent versus non-covalent, reversible versus non-reversible binding. Very recently, Haselmann et al. reported the analysis of a non-covalently bound complex of a modified glycopeptide antibiotic with its target peptide using ECD FT-ICR MS [31] . Here, we seek to exploit ECD's preference for cleavage of disulfide bonds as a method to detect DFC attachment to peptides and proteins through disulfide bonds. We also discuss the feasibility of combining ECD FT-ICR MS with high performance liquid chromatography (HPLC) as a screening technique for the detection of DFC attachment to plasma and tissue proteins. To the best of our knowledge, the present results constitute the first reported use of ECD FT-ICR MS to analyze the binding of a covalently bound drug/biomolecule complex. Portions of this work were previously presented in abstract form [32] .
Materials and Methods
Bovine insulin and [Arg 8 ]-vasopressin (C-terminal amide) were purchased from ICN Pharmaceuticals (Costa Mesa, CA). Ceftiofur was graciously provided by Rex Hornish (Pharmacia Animal Health, Kalamazoo, MI). The reaction of ceftiofur and vasopressin was as follows: Ceftiofur was first dissolved in methanol after which an equal amount of water was added to generate a 2 ϫ 10 Ϫ4 M ceftiofur solution. 0.25 mL of a ϳ0.02 M solution of sodium hydroxide (pH ϳ 11-12) was then added to 1.0 mL of the ceftiofur solution to generate desfuruoylceftiofur (DFC) as shown in Figure 1 [33] . The mixture was allowed to react at 36 -40°C for 10 -30 min in a heated sonicator or temperature controlled water bath. The solution was then acidified with 0.3 mL of 0.1% formic acid to reduce the pH before reacting the ceftiofur solution with the peptide. 0.2 mg of Arg 8 -vasopressin was added to the solution and reacted for 1 h at 40°C in a temperature controlled water bath. The final solution was then diluted 100-fold in water to provide a working concentration and to further dilute the salts in the sample.
The reaction of ceftiofur and bovine insulin was as follows. The starting solutions were: 0.17 M solution of ammonium hydroxide (pH ϭ 10.5); 0.1% formic acid solution (pH ϭ 3.2); 2.0 ϫ 10 Ϫ4 M solution of ceftiofur in 1:1 (MeOH:H 2 O); 1.0 ϫ 10 Ϫ4 M solution of insulin in water. 1.0 mL of ceftiofur solution was reacted with 0.5 mL of NH 4 OH for 30 min at 40°C in a temperaturemonitored sonicator. 0.5 mL of 0.1% formic acid was then added, lowering the pH to ϳ7. 1.0 ml of the insulin solution was then added to this solution and allowed to react at 40°C for 55 min. Finally, the solution was further acidified with formic acid until the pH was 3.2, and then, 1.0 ml of MeOH was added to facilitate electrospray.
Samples were analyzed with a homebuilt, passively shielded, 9.4 tesla FT-ICR mass spectrometer [34] . Samples were introduced into the mass spectrometer by a direct infusion microelectrospray source [35] using a syringe pump (Harvard Apparatus, Inc., Holliston, MA) operated at 400 nL/min. 2 kV was applied between the microspray emitter and the heated capillary entrance. The magnitude of the parent ions of interest were increased by mass-selective external ion accumulation employing a quadrupole mass filter [36] . A finer isolation was achieved by stored waveform inverse Fourier transform (SWIFT) mass-selective ion ejection [37] . The isolated ions were then irradiated with low energy electrons for 50 ms. An indirectly-heated electron dispenser cathode (10 mm diameter, no. 1109, Heatwave, Watsonville, CA) was used for electron irradiation [15] [16] [17] . 
Results and Discussion

(DFC-H) ϩ 2H]
ϩ ⅐ is also weak. The low abundances of these species may reflect their instability given the amount of internal energy deposited into the molecule during the recombination process. The most abundant fragment ions in Figure 2 correspond to ␤-lactam ring cleavage (m/z 1700) and dissociative loss of one DFC, but without its thiyl sulfur (m/z 1544). These fragmentations are schematically shown in Figure 3 and could originate from dissociative losses from either [vasopres-
ϩ . Based on accurate mass measurement, we have tentatively identified the peak at m/z 1910 as dissociative loss of a methoxy group from [vasopressin ϩ
2(DFC-H) ϩ 2H]
ϩ⅐ , presumably from the imino-methoxy group of DFC. That fragmentation is also schematically shown in Figure 3 . 
Sites of Protonation of [Vasopressin ϩ 2(DFC-H) ϩ 2H] 2ϩ
To our knowledge, there are no measurements of the gas-phase proton affinity or gas-phase basicity of ceftiofur or DFC. However, the most likely protonation site for DFC is the 2-aminothiazole functional group, whose proton affinity (PA) is 222.4 kcal/mol [38] . In Figure 4 , we have identified the most likely protonation sites in the [vasopressin ϩ 2(DFC-H)] complex along with their gas phase PA's. We find that the PA of DFC is 7.7 kcal/mol greater than the PA of the N-terminal amine. The most likely protonation sites of [vasopressin ϩ
2(DFC-H) ϩ 2H]
2ϩ are therefore the side-chain of the Arg 8 , and either the DFC attached to Cys 1 or the peptide N-terminus. Such configurations would place protons on the most basic sites in the complex while at the same time minimizing the Coulomb repulsion between the two charges.
As mentioned previously, the most abundant fragment ions in Figure 2 are ␤-lactam ring cleavage (resulting in a fragment ion at m/z 1700), and dissociative loss of a DFC minus a sulfur atom, (resulting in a fragment ion at m/z 1544). Both fragmentation channels are also dominant channels in the collision-induced dissociation (CID) of [M ϩ H] ϩ of desfuroylceftiofur cysteine disulfide (DCCD), a biomarker of ceftiofur [39] . The loss of a methoxy group from [vasopressin ϩ
ϩ⅐ is interesting because this dissociative loss is not observed in the CID of DCCD [39] . Figure 5 shows the mass spectrum following ECD of
ECD of [Insulin ϩ DFC ϩ 4H] 4ϩ
4ϩ is the mass of insulin plus the mass of one DFC molecule plus the mass of four protons). We find far fewer fragmentation channels than were observed from ECD of 
Sites of Protonation of [Insulin ϩ DFC ϩ 4H] 4ϩ
Bovine insulin is a two-chain (A and B) protein with four basic residues: Two histidines, one lysine, and one arginine, all located on the B-chain. Two disulfide bonds connect the A and B chains. The A-chain has one intrachain disulfide bond. Figure 6 shows one possible configuration for [insulin ϩ DFC] (the gas phase PA's of the 2-aminothiazole group of DFC and the four basic residues are also shown), however, one cannot determine with complete certainty the protonation sites (or even the site of DFC attachment for [insulin ϩ DFC ϩ 4H] 4ϩ ). Although the 2-aminothiazole group of DFC has a PA that is less than that of the side-chains of basic residues, it is possible that DFC could be protonated if it reduced the Coulomb repulsion that might occur if all four protons were located on the B-chain.
Bond Cleavage by ECD
It is interesting to note that there is no significant peptide backbone cleavage observed in the ECD spectra of [vasopressin ϩ 2(DFC-H) ϩ 2H] 2ϩ and [insulin ϩ DFC ϩ 4H] 4ϩ . The process which results in efficient cleavage of disulfide bonds in these complexes appears to also result in a concomitant lack of peptide backbone cleavages (although we do observe fragmentation of the antibiotic adducts for ECD of [vasopressin ϩ 2(DFC-H) ϩ 2H] 2ϩ ). One can only conclude that the antibiotic/peptide (and antibiotic/ protein) disulfide bond would appear to have a significantly higher efficiency for cleavage than that of the peptide backbone. Longer electron irradiation times did not significantly alter our results. Previous researchers have similarly noted a reduction of peptide backbone cleavage in ECD spectra of peptides and proteins that have intramolecular disulfide bonds [13] . It is possible that use of "hot" ECD may lead to more extensive cleavage of these antibiotic/peptide (protein) complexes, including the peptide backbone, and thus might give more specific information about the positions of antibiotic attachment (assuming antibiotic attachment is not completely lost). However, in the present study, we deliberately exploit the preference of ECD to cleave disulfide bonds to confirm the nature of antibiotic/peptide (protein) binding and thus, the sites of attachment, i.e., cysteine residues. Given the facile loss of DFC from ECD of DFC/vasopressin and DFC/insulin complexes, future experiments might involve ECD of antibiotic/ protein complexes for larger proteins, e.g., lysozyme or bovine serum albumin. Such experiments would have both a practical utility (a screening method for DFC attached to larger proteins) as well as theoretical value (what is the largest protein for which one observes ECD dissociative loss of a covalently bound drug adduct). 
Conclusions
The facile loss of DFC from [vasopressin ϩ 2(DFC-H) ϩ 2H] 2ϩ and [insulin ϩ DFC ϩ 4H] 4ϩ when subjected to ECD suggests that DFC is indeed bound to proteins through disulfide bonds. In addition, ECD of [vasopressin ϩ 2(DFC-H) ϩ 2H] 2ϩ may also occur by H⅐ atom ejection followed by ergodic dissociations, which may include a rearrangement/fragmentation that transfers a hydrogen atom from a DFC to the peptide [39] . However, ECD of [insulin ϩ (DFC) ϩ 4H] 4ϩ does not seem to occur by that mechanism because H⅐ atom ejection is not observed. Gas-phase disulfide exchange appears to play a partial role in the loss of two DFCs during ECD of [vasopressin ϩ 2(DFC-H) ϩ 2H] 2ϩ , and in loss of one DFC and a hydrogen atom (loss of 430) from ECD of [insulin ϩ DFC ϩ 4H] 4ϩ . It has been documented that the binding of DFC to plasma and tissue proteins extends the half-life of the antibiotic [40] . In consequence, much of the residual ceftiofur is in the form of protein-bound DFC and thus constitutes an antibiotic residue. The facile loss of DFC from vasopressin/DFC and insulin/DFC suggests that, if coupled with HPLC, ECD FT-ICR MS may prove to be a valuable technique for the detection of DFC attached to proteins. In contrast to current methods, which require chemical modifications/derivatizations prior to analysis [1, 2] , the present technique is sensitive, accurate, and requires less chemical manipulations that can lead to additional sample loss. 
